Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders?
Kuehn Law Encourages Investors of Agilon Health, Inc. to Contact Law Firm
Agilon Health (AGL) had its price target lowered by Citigroup Inc. from $0.85 to $0.75. They now have a "neutral" rating on the stock.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 2, 2026 in agilon health, inc. Lawsuit – AGL
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm